The polymorphism of IL28B was described as important in the pathogenesis of infections caused by some viruses. The aim of this research was to evaluate whether IL28B gene polymorphisms (SNP rs8099917 and SNP rs12979860) were associated with HAM/TSP. The study included 144 subjects were classified according to their neurological status in two groups: Group I (60 asymptomatic HTLV-1 carriers) and Group II (84 HAM/TSP patients). Blood samples were collected, and PBMC separated by Ficoll density gradient centrifugation. DNA was extracted using a commercial kit, and the DNA was stored at -80°C for later analysis. After this, the proviral load was quantified, and the rs8099917 and rs12979860 SNPs in the region of IL28B-gene were analyzed by StepOnePlus Real-time PCR System. A multivariate model analysis, including gender, age, and HTLV-1 DNA proviral load, showed that IL28B polymorphism SNP rs12979860 was not independently associated with HAM/TSP outcome. In contrast, the SNP rs8099917 allele GG was independently associated with HAM/TSP outcome (OR=6.25; IC95%=1.22-32.00). Persons with SNP rs8099917 genotype GG may present a distinct immune response against HTLV-1 infection. So, it seems reasonable to suggest that a search for IL28B polymorphisms should be performed for all HTLV-1-infected subjects in order to monitor their risk for disease development; however, since this is the first description of this finding in the literature, we should first replicate this study with more HTLV-1-infected persons to strengthen the evidence already provided by our results.
Background: The polymorphism of IL28B was described as important in the pathogenesis of infections caused by some viruses. The aim of this research was to evaluate whether IL28B gene polymorphisms (SNP rs8099917 and SNP rs12979860) were associated with HAM/TSP. Methods: The study included 188 patients of the Institute of Infectious Diseases "Emilio Ribas" of São Paulo, they formed three groups: 117 subjects infected with HTLV-1(49 asymptomatic and 68 with HAM TSP), 47 chronic HCV monoinfected patients and 24 co-infected with HTLV-1 and HCV. Blood samples were collected and PBMC separated by density gradient centrifugation in Ficoll-Hypaque. DNA was extracted using a commercial kit, and the DNA was stored at-80 ° C for later analysis. Thereafter, the proviral load of individuals with HTLV-1 was quantified SNPs rs12979860 and rs8099917 in the region of IL28B were analyzed in all groups by PCR StepOnePlus system in real time. Results: A multivariate model analysis, including gender, age, and HTLV-1 DNA proviral load, showed that IL28B polymorphism SNP rs12979860 was not independently associated with HAM/TSP outcome. In contrast, the SNP rs8099917 allele GG was independently associated with HAM/TSP outcome (OR=6.25; IC95%=1.22-32.00). Conclusion: Persons with SNP rs8099917 genotype GG may present a distinct immune response against HTLV-1 infection. So, it seems reasonable to suggest that a search for IL28B polymorphisms should be performed for all HTLV-1-infected subjects in order to monitor their risk for disease development; however, since this is the first description of this finding in the literature, we should first replicate this study with more HTLV-1-infected persons to strengthen the evidence already provided by our results.
JAK/STAT Janus quinase e transdutor de sinal e ativador de transcrição KIR Receptores inibitórios de células natural killer KIR2DL3 Receptores inibitórios de células natural killer KIR2DL3 KIR2DL Receptores inibitórios de células natural killer KIR2DL KIR2DL1 Receptores inibitórios de células natural killer KIR2DL1 KIR2DL2 Receptores inibitórios de células natural killer KIR2DL2 KIR2DS1 Receptores inibitórios de células natural killer KIR2DS1 KIR2DS2 Receptores inibitórios de células natural killer KIR2DS2
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.